MLANA Antikörper (AA 48-118)
-
- Target Alle MLANA Antikörper anzeigen
- MLANA (Melan A (MLANA))
-
Bindungsspezifität
- AA 48-118
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MLANA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Sequenz
- CRRRNGYRAL MDKSLHVGTQ CALTRRCPQE GFDHRDSKVS LQEKNCEPVV PNAPPAYEKL SAEQSPPPYS P
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 48-118 of human MLANA (NP_005502.1).
- Isotyp
- IgG
- Top Product
- Discover our top product MLANA Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
- Kommentare
-
HIGH QUALITY
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- MLANA (Melan A (MLANA))
- Andere Bezeichnung
- MLANA (MLANA Produkte)
- Synonyme
- A930034P04Rik antikoerper, Mart1 antikoerper, MART-1 antikoerper, MART1 antikoerper, melan-A antikoerper, Mlana antikoerper, MLANA antikoerper
- Hintergrund
- Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.,MLANA,MART-1,MART1,melan-A,Cancer,Tumor immunology,Tumor-associated antigens,Immunology & Inflammation,MLANA
- Molekulargewicht
- 13 kDa
- Gen-ID
- 2315
- UniProt
- Q16655
-